---
figid: PMC5189614__theoncologist_15519_f1
figlink: /pmc/articles/PMC5189614/figure/F1/
number: Figure 1
caption: 'Cellular control of hyperglycemia. Glucose homeostasis is maintained at
  a cellular level through activation of the intracellular PI3K/AKT/mTOR pathway downstream
  of IGF-1R and IR. These receptors, along with EGFR, can also activate the Ras/MAPK/ERK
  pathway, which plays a role in cellular proliferation and survival. Targeted therapies
  designed to inhibit cancer cell proliferation and promote apoptosis act on these
  pathways at multiple points (red circles).Abbreviations: EGF, epidermal growth factor;
  EGFR, epidermal growth factor receptor; IGF, insulin growth factor; IGF-1R, insulin
  growth factor receptor 1; IR, insulin receptor.'
pmcid: PMC5189614
papertitle: 'Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms
  and Management.'
reftext: Jonathan W. Goldman, et al. Oncologist. 2016 Nov;21(11):1326-1336.
pmc_ranked_result_index: '95107'
pathway_score: 0.8653776
filename: theoncologist_15519_f1.jpg
figtitle: Cellular control of hyperglycemia
year: '2016'
organisms: Homo sapiens
ndex: 99a1658f-df15-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5189614__theoncologist_15519_f1.html
  '@type': Dataset
  description: 'Cellular control of hyperglycemia. Glucose homeostasis is maintained
    at a cellular level through activation of the intracellular PI3K/AKT/mTOR pathway
    downstream of IGF-1R and IR. These receptors, along with EGFR, can also activate
    the Ras/MAPK/ERK pathway, which plays a role in cellular proliferation and survival.
    Targeted therapies designed to inhibit cancer cell proliferation and promote apoptosis
    act on these pathways at multiple points (red circles).Abbreviations: EGF, epidermal
    growth factor; EGFR, epidermal growth factor receptor; IGF, insulin growth factor;
    IGF-1R, insulin growth factor receptor 1; IR, insulin receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - IRS4
  - IRS2
  - EGFR
  - PIK3CA
  - MAPK3
  - IGF1R
  - IRS1
  - ARAF
  - EGF
  - SHC4
  - SOS1
  - GRB2
  - PIK3CG
  - PIK3R3
  - BRAF
  - PIK3CB
  - SHC1
  - RAF1
  - MAP2K1
  - PIK3CD
  - PIK3R6
  - SHC2
  - AKT2
  - NRAS
  - MAP2K2
  - PIK3R5
  - PIK3R4
  - MTOR
  - AKT3
  - KRAS
  - AKT1
  - SHC3
  - HRAS
  - SOS2
  - rociletinib
  - afuresertib
  - temsirolimus
  - ridaforolimus
  - BEZ235
  - PF-05212384
  - PKI-587
  - linsitinib
  - GDC-0980
  - PF-04691502
  - ceritinib
  - Glucose
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
chemicals:
- word: rociletinib
  source: MESH
  identifier: C000589977
- word: afuresertib
  source: MESH
  identifier: C000593263
- word: temsirolimus
  source: MESH
  identifier: C401859
- word: ridaforolimus
  source: MESH
  identifier: C515074
- word: BEZ235
  source: MESH
  identifier: C531198
- word: PF-05212384
  source: MESH
  identifier: C549060
- word: PKI-587
  source: MESH
  identifier: C549060
- word: linsitinib
  source: MESH
  identifier: C551528
- word: GDC-0980
  source: MESH
  identifier: C569670
- word: PF-04691502
  source: MESH
  identifier: C570662
- word: ceritinib
  source: MESH
  identifier: C586847
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
